| Filed On | Filing |
|---|---|
| 04 Jun 2024 |
Form 4: Bitetti Teresa Marie, Director
Disposed of 34,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Gannon Steven, Director
Returned 56,400 shares to the issuer · Disposed of 222,011 Stock Option (Right to Buy) (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Valliant John, Director
Returned 318,147 shares to the issuer · Disposed of 3,726,133 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 192,200 Restricted Stock Units (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Cagnoni Pablo J, Director
Disposed of 222,011 Stock Option (Right to Buy) (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Lee Philina, Director
Disposed of 81,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Duncan Barbara Gayle, Director
Disposed of 81,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Burak Eric, Chief Technology Officer
Returned 38,490 shares to the issuer · Disposed of 1,261,929 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 63,700 Restricted Stock Units (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Leamon Christopher P, Chief Scientific Officer
Returned 11,957 shares to the issuer · Disposed of 574,100 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 63,700 Restricted Stock Units (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Bergstrom Donald A, Director
Disposed of 85,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Rawat Mohit, President & CBO
Returned 21,699 shares to the issuer · Disposed of 770,400 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 81,300 Restricted Stock Units (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Crowley John J, Chief Financial Officer
Returned 10,410 shares to the issuer · Disposed of 1,100,844 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 63,700 Restricted Stock Units (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Meek David D., Director
Disposed of 34,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Bobilev Dmitri, Chief Medical Officer
Disposed of 701,700 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 91,000 Restricted Stock Units (Disposition to Issuer) |
| 04 Jun 2024 |
Form 4: Bender Jeremy, Director
Disposed of 34,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 05 Jan 2024 |
Form 4: Leamon Christopher P, Chief Scientific Officer
Received 11,957 shares as a grant or award · Granted 106,100 Stock Option (Right to Buy) · Granted 63,700 Restricted Stock Units |
| 05 Jan 2024 |
Form 4: Crowley John J, Chief Financial Officer
Granted 106,100 Stock Option (Right to Buy) · Granted 63,700 Restricted Stock Units |
| 05 Jan 2024 |
Form 4: Burak Eric, Chief Technology Officer
Granted 106,100 Stock Option (Right to Buy) · Granted 63,700 Restricted Stock Units |
| 05 Jan 2024 |
Form 4: Rawat Mohit, President & CBO
Received 12,843 shares as a grant or award · Granted 135,500 Stock Option (Right to Buy) · Granted 81,300 Restricted Stock Units |
| 05 Jan 2024 |
Form 4: Bobilev Dmitri, Chief Medical Officer
Granted 151,700 Stock Option (Right to Buy) · Granted 91,000 Restricted Stock Units |
| 05 Jan 2024 |
Form 4: Valliant John, Director
Granted 320,400 Stock Option (Right to Buy) · Granted 192,200 Restricted Stock Units |
Loading...
